Xenon Pharmaceuticals Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| PIMSTONE SIMON N. | CEO | Tax Withholding | 1,108 | $14.90 | $16,509 | 263,186 | May 26, 2020 |
| AZAB MOHAMMAD | — | Option Exercise | 3,086 | $3.56 | $10,986 | 60,647 | Dec 16, 2019 |
| PATOU GARY | — | Option Exercise | 2,057 | $3.56 | $7,323 | 21,516 | Dec 4, 2019 |
| TARNOW MICHAEL M | — | Gift | 5,144 | — | — | 64,569 | Nov 21, 2019 |
| PIMSTONE SIMON N. | CEO | Sale | 10,395 | $9.51 | $98,856 | 258,122 | Sep 20, 2019 |
| HOLLER FRANK A | — | Sale | 5,206 | $9.39 | $48,884 | 118,955 | Sep 19, 2019 |
| HOLLER FRANK A | — | Sale | 5,069 | $9.32 | $47,243 | 136,129 | Sep 18, 2019 |
| PIMSTONE SIMON N. | CEO | Tax Withholding | 2,769 | $9.44 | $26,139 | 259,864 | Sep 17, 2019 |
| AZAB MOHAMMAD | — | Sale | 23 | $9.31 | $214 | 57,561 | Sep 13, 2019 |
| HOLLER FRANK A | — | Tax Withholding | 934 | $9.38 | $8,761 | 121,107 | Sep 12, 2019 |
| ROBIN SHERRINGTON | EVP, Strategy & Innovation | Tax Withholding | 1,868 | $9.38 | $17,522 | 10,196 | Sep 12, 2019 |
| TARNOW MICHAEL M | — | Option Exercise | 2,057 | $3.21 | $6,603 | 64,569 | May 21, 2019 |
| Hayden Michael R | — | Option Exercise | 20,576 | $3.38 | $69,547 | 50,924 | Mar 19, 2019 |
| Hayden Michael R | — | Gift | 24,045 | — | — | 107,562 | Mar 11, 2019 |
| TARNOW MICHAEL M | — | Gift | 5,000 | — | — | 62,512 | Dec 21, 2018 |
| PATOU GARY | — | Option Exercise | 2,057 | $3.07 | $6,315 | 19,459 | Dec 14, 2018 |
| COHEN CHARLES J. | VP, Biology | Option Exercise | 4,115 | $3.07 | $12,633 | 8,194 | Dec 11, 2018 |
| AZAB MOHAMMAD | — | Option Exercise | 3,086 | $3.07 | $9,474 | 57,584 | Dec 6, 2018 |
| TARNOW MICHAEL M | — | Option Exercise | 2,057 | $3.66 | $7,529 | 62,368 | Jun 21, 2018 |
| AZAB MOHAMMAD | — | Option Exercise | 10,288 | $3.70 | $38,066 | 54,498 | Jun 21, 2018 |
| PATOU GARY | — | Option Exercise | 8,230 | $3.70 | $30,451 | 20,258 | Jun 14, 2018 |
| LAMPERT MARK N | — | Other | 861,000 | — | — | 216,694 | Mar 27, 2018 |
| ROBIN SHERRINGTON | EVP Bus. & Corp. Development | Option Exercise | 3,086 | $3.77 | $11,634 | 7,820 | Mar 15, 2018 |
| HOLLER FRANK A | — | Option Exercise | 3,086 | $3.77 | $11,634 | 118,955 | Mar 14, 2018 |
| PIMSTONE SIMON N. | CEO | Option Exercise | 10,288 | $3.77 | $38,786 | 228,135 | Mar 12, 2018 |
| Hayden Michael R | — | Gift | 21,180 | — | — | 97,066 | Feb 22, 2018 |
| COHEN CHARLES J. | VP, Biology | Tax Withholding | 22,669 | $3.50 | $79,342 | 4,079 | Feb 12, 2018 |
| AZAB MOHAMMAD | — | Purchase | 15,000 | $2.22 | $33,300 | 44,210 | Nov 15, 2017 |
| AZAB MOHAMMAD | — | Purchase | 8,000 | $2.95 | $23,600 | 29,210 | Sep 21, 2017 |
| WINQUIST RAYMOND | Head, Translational Research | Purchase | 1,000 | $3.00 | $3,000 | 1,000 | Aug 18, 2017 |
| AZAB MOHAMMAD | — | Purchase | 6,312 | $2.90 | $18,305 | 19,210 | Aug 17, 2017 |
| EMPFIELD JAMES R. | SVP, Drug Discovery | Purchase | 10,000 | $2.48 | $24,800 | 10,000 | Aug 15, 2017 |
| BIOTECHNOLOGY VALUE FUND II LP | — | Purchase | 7,429 | $2.41 | $17,904 | 1,077,694 | Aug 14, 2017 |
| Svoronos Dawn | — | Purchase | 50,000 | $2.82 | $141,000 | 50,000 | Aug 14, 2017 |
| Hayden Michael R | — | Purchase | 15,000 | $2.75 | $41,250 | 161,187 | Aug 14, 2017 |
| GANNON STEVEN | — | Purchase | 15,000 | $2.82 | $42,300 | 15,000 | Aug 11, 2017 |
| PATOU GARY | — | Purchase | 7,500 | $2.78 | $20,850 | 12,500 | Aug 10, 2017 |
| MORTIMER IAN | CFO & COO | Purchase | 10,000 | $2.90 | $29,000 | 14,300 | Aug 10, 2017 |
| SCHELLER RICHARD H | — | Purchase | 7,000 | $2.85 | $19,950 | 7,000 | Aug 10, 2017 |
| PIMSTONE SIMON N. | President & CEO | Purchase | 6,000 | $2.90 | $17,400 | 217,847 | Aug 10, 2017 |
| PATOU GARY | — | Purchase | 5,000 | $3.00 | $15,000 | 5,000 | Aug 8, 2017 |
| BIOTECHNOLOGY VALUE FUND L P | — | Purchase | 46,795 | $3.04 | $142,257 | 1,635,032 | Jun 27, 2017 |
| BVF Partners OS Ltd. | — | Purchase | 8,496 | $4.00 | $33,984 | 297,464 | Jun 27, 2017 |
| LAMPERT MARK N | — | Purchase | 4,406 | $4.00 | $17,624 | 1,023,874 | Jun 22, 2017 |
| TARNOW MICHAEL M | — | Gift | 1,028 | — | — | 55,167 | Jun 19, 2017 |
| BVF PARTNERS L P/IL | — | Purchase | 3,845 | $3.84 | $14,765 | 1,014,324 | Jun 19, 2017 |
| BVF PARTNERS L P/IL | — | Purchase | 20,594 | $3.85 | $79,287 | 284,171 | Jun 6, 2017 |
| ROBIN SHERRINGTON | SVP Bus. & Corp. Development | Tax Withholding | 1,345 | $4.18 | $5,622 | 4,734 | May 12, 2017 |
| Hayden Michael R | — | Option Exercise | 4,629 | $3.07 | $14,211 | 27,262 | Mar 14, 2017 |
| TARNOW MICHAEL M | — | Gift | 7,201 | — | — | 55,167 | Jan 26, 2017 |